SYNTHETIC STRATEGIES IN DRUG DISCOVERY: EMPLOYNG DIVERSITY-ORIENTED SYNTHESIS

Drug discovery often involves screening synthetic small molecules for their ability to bind to a macromolecular target. Target-Oriented Synthesis of a specific compound or a focused library can be planned combining retrosynthetic analysis and rational drug design. Biologically active molecules also can be identified through the unfocused screening of compound libraries. Diversity-Oriented Synthesis (DOS) emerges as an excellent strategy that leads to a library of structurally complex and diverse small molecules, covering a larger chemical space and increasing the probability of identifying modulators